Difference between revisions of "STROKE-CHADSVASC SCORE"
(Imported from text file) |
(Imported from text file) |
||
| Line 1: | Line 1: | ||
===== [[Summary Article|'''SUMMARY''']] ===== | ===== [[Summary Article|'''SUMMARY''']] ===== | ||
CHADS<sub>2</sub> | CHADS<sub>2</sub> SCORE | ||
<br/>1. Congestive cardiac failure (EF < 35%): 1 point | |||
<br/>2. Hypertension (SBP > 160mmHg or treated hypertension): 1 point | <br/>2. Hypertension (SBP > 160mmHg or treated hypertension): 1 point | ||
<br/>3. Age >= 75yr: 1 point | <br/>3. Age >= 75yr: 1 point | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
CHADS2 SCORE
1. Congestive cardiac failure (EF < 35%): 1 point
2. Hypertension (SBP > 160mmHg or treated hypertension): 1 point
3. Age >= 75yr: 1 point
4. Diabetes: 1 point
5. Stroke (prior stroke or TIA): 2 points
CHADS2 TREATMENT RECOMMENDATIONS (Gage et al, Selecting patients with AF for anticoagulation: stroke risk stratification in patients taking Aspirin)
1. SCORE 0: Aspirin 75-80mg daily
2. SCORE 1-2: Aspirin 75-80mg daily OR Warfarin target INR 2-3
3. SCORE 3-6: Warfarin target INR 2-3
Reference(s)
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
